Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paul Hammerness

Showing results (1-10 of 68) with videos related to

Pageof 7
Sort By:
Current Neurology and Neuroscience Reports|October 30, 2008
Update on adult attention-deficit/hyperactivity disorderPaul Hammerness, Craig Surman, Katherine Miller
Psychosomatics|June 21, 2002
Linezolid: MAOI activity and potential drug interactionsPaul Hammerness, Hector Parada, Annah Abrams
Current Opinion in Pediatrics|December 12, 2018
New stimulant formulations for pediatric attention-deficit/hyperactivity disorder: a case-based approach for the primary care providerPaige I Partain, Jacob White, Paul Hammerness
Journal of the American Academy of Child and Adolescent Psychiatry|December 20, 2014
Corrected QT interval changes with atypical antipsychoticsKaizad Munshi, Mark E Alexander, Paul Hammerness
Journal of Herbal Pharmacotherapy|July 28, 2004
Marshmallow (Althaea officinalis L.) monographEthan Basch, Catherine Ulbricht, Paul Hammerness, et al.
Journal of Attention Disorders|December 25, 2012
Do Stimulants Reduce the Risk for Alcohol and Substance Use in Youth With ADHD? A Secondary Analysis of a Prospective, 24-Month Open-Label Study of Osmotic-Release MethylphenidatePaul Hammerness, Carter Petty, Stephen V Faraone, et al.
Child and Adolescent Psychiatric Clinics of North America|June 13, 2022
Cardiovascular Considerations for Stimulant Class MedicationsPaul Hammerness, Amy Berger, Michael C Angelini, et al.
Neuropsychiatric Disease and Treatment|June 27, 2009
Atomoxetine for the treatment of attention-deficit/hyperactivity disorder in children and adolescents: a reviewPaul Hammerness, Katherine McCarthy, Elizabeth Mancuso, et al.
Child Neuropsychology : a Journal on Normal and Abnormal Development in Childhood and Adolescence|May 4, 2013
Assessment of cognitive domains during treatment with OROS methylphenidate in adolescents with ADHDPaul Hammerness, Ronna Fried, Carter Petty, et al.
Journal of Herbal Pharmacotherapy|July 27, 2004
Thyme (Thymus vulgaris L.), thymolEthan Basch, Catherine Ulbricht, Paul Hammerness, et al.
Pageof 7

Showing results (1-10 of 68) with videos related to

Sort By:
Pageof 7
Current Neurology and Neuroscience Reports|October 30, 2008
Update on adult attention-deficit/hyperactivity disorderPaul Hammerness, Craig Surman, Katherine Miller
Psychosomatics|June 21, 2002
Linezolid: MAOI activity and potential drug interactionsPaul Hammerness, Hector Parada, Annah Abrams
Current Opinion in Pediatrics|December 12, 2018
New stimulant formulations for pediatric attention-deficit/hyperactivity disorder: a case-based approach for the primary care providerPaige I Partain, Jacob White, Paul Hammerness
Journal of the American Academy of Child and Adolescent Psychiatry|December 20, 2014
Corrected QT interval changes with atypical antipsychoticsKaizad Munshi, Mark E Alexander, Paul Hammerness
Journal of Herbal Pharmacotherapy|July 28, 2004
Marshmallow (Althaea officinalis L.) monographEthan Basch, Catherine Ulbricht, Paul Hammerness, et al.
Journal of Attention Disorders|December 25, 2012
Do Stimulants Reduce the Risk for Alcohol and Substance Use in Youth With ADHD? A Secondary Analysis of a Prospective, 24-Month Open-Label Study of Osmotic-Release MethylphenidatePaul Hammerness, Carter Petty, Stephen V Faraone, et al.
Child and Adolescent Psychiatric Clinics of North America|June 13, 2022
Cardiovascular Considerations for Stimulant Class MedicationsPaul Hammerness, Amy Berger, Michael C Angelini, et al.
Neuropsychiatric Disease and Treatment|June 27, 2009
Atomoxetine for the treatment of attention-deficit/hyperactivity disorder in children and adolescents: a reviewPaul Hammerness, Katherine McCarthy, Elizabeth Mancuso, et al.
Child Neuropsychology : a Journal on Normal and Abnormal Development in Childhood and Adolescence|May 4, 2013
Assessment of cognitive domains during treatment with OROS methylphenidate in adolescents with ADHDPaul Hammerness, Ronna Fried, Carter Petty, et al.
Journal of Herbal Pharmacotherapy|July 27, 2004
Thyme (Thymus vulgaris L.), thymolEthan Basch, Catherine Ulbricht, Paul Hammerness, et al.
Pageof 7